8488 related articles for article (PubMed ID: 2001543)
1. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
Wahl RL; Hutchins GD; Buchsbaum DJ; Liebert M; Grossman HB; Fisher S
Cancer; 1991 Mar; 67(6):1544-50. PubMed ID: 2001543
[TBL] [Abstract][Full Text] [Related]
2. Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies.
Wahl RL; Harney J; Hutchins G; Grossman HB
J Urol; 1991 Dec; 146(6):1470-4. PubMed ID: 1942320
[TBL] [Abstract][Full Text] [Related]
3. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
[TBL] [Abstract][Full Text] [Related]
4. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes.
Wahl RL; Kaminski MS; Ethier SP; Hutchins GD
J Nucl Med; 1990 Nov; 31(11):1831-5. PubMed ID: 2230996
[TBL] [Abstract][Full Text] [Related]
5. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma.
Brown RS; Fisher SJ; Wahl RL
J Nucl Med; 1993 Jan; 34(1):75-82. PubMed ID: 8418275
[TBL] [Abstract][Full Text] [Related]
7. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
9. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Yoshioka T; Takahashi H; Oikawa H; Maeda S; Ido T; Akaizawa T; Fukuda H; Kanamaru R
J Nucl Med; 1997 May; 38(5):714-7. PubMed ID: 9170434
[TBL] [Abstract][Full Text] [Related]
10. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
11. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.
Osman S; Danpure HJ
Int J Rad Appl Instrum B; 1992 Feb; 19(2):183-90. PubMed ID: 1601671
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Shulkin BL; Hutchinson RJ; Castle VP; Yanik GA; Shapiro B; Sisson JC
Radiology; 1996 Jun; 199(3):743-50. PubMed ID: 8637999
[TBL] [Abstract][Full Text] [Related]
13. A kinetic comparison of [18F]2-fluoro-2-deoxyglucose and [18F]2-fluoro-2-deoxymannose using positron emission tomography.
Braun AR; Carson RE; Adams HR; Finn RD; Francis BE; Herscovitch P
Nucl Med Biol; 1994 Aug; 21(6):857-63. PubMed ID: 9234335
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
[TBL] [Abstract][Full Text] [Related]
16. Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
Wahl RL; Cody R; Hutchins G; Mudgett E
N Engl J Med; 1991 Jan; 324(3):200. PubMed ID: 1984203
[No Abstract] [Full Text] [Related]
17. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
18. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF
Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
[TBL] [Abstract][Full Text] [Related]
19. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
20. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Gritters LS; Francis IR; Zasadny KR; Wahl RL
J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
